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Abstract
Genomic data generated from clinical Vibrio cholerae O1 isolates collected over a five year
period in an area of Kolkata, India with seasonal cholera outbreaks allowed a detailed
genetic analysis of serotype switching that occurred from Ogawa to Inaba and back to
Ogawa. The change from Ogawa to Inaba resulted from mutational disruption of the
methyltransferase encoded by the wbeT gene. Re-emergence of the Ogawa serotype was
found to result either from expansion of an already existing Ogawa clade or reversion of the
mutation in an Inaba clade. Our data suggests that such transitions are not random events
but rather driven by as yet unidentified selection mechanisms based on differences in the
structure of the O1 antigen or in the serotype-determining wbeT gene.
Author Summary
Cholera is a major health problem in many parts of the world causing seasonal outbreaks
in endemic areas. Essentially only the O1 serogroup of Vibrio cholerae causes epidemic
cholera. This serogroup has two immunologically distinguishable serotype variants
called Ogawa and Inaba. The Inaba serotype is a consequence of a mutation in a single
gene, wbeT, that in its intact form encodes for an enzyme that methylates the terminal
perosamine sugar of the lipopolysaccharide side chain thus resulting in the Ogawa sero-
type. By careful examination over a five-year period of the genetic lineages of bacteria
causing cholera in an endemic area we show data indicating that serotype switching is
not a random process but is driven by selection pressures that have yet to be identified.
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Introduction
Cholera is the most severe of all infectious diarrheal diseases, which if not adequately treated
can have a high mortality up to 50%. It is caused by Vibrio cholerae bacteria of serogroup O1,
whose propensity for epidemic and even pandemic spread can have devastating effects in
terms of morbidity and mortality. Recent examples of severe epidemics leading to many thou-
sands of deaths are those that occurred in Zimbabwe and Haiti [1, 2]. Over the past nearly two
centuries seven pandemics have been documented [3]. The first six pandemics are believed to
have been caused by V. cholerae of the Classical biotype whereas the current ongoing pandemic
that started in the early 1960’s is caused by organisms of the El Tor biotype [4]. Despite signifi-
cant physiological and biochemical differences the two V. cholerae biotypes express almost
identical virulence factors (including cholera toxin) and the same surface lipopolysaccharide
(LPS). Both have the same O1 serogroup which, along with the relatively rarely seen serotype
O139 (currently<0.1% globally and only occurring in South Asia), are the only V. cholerae
known to cause epidemic or pandemic cholera [4].
In both biotypes the O1 serogroup can be further subdivided into two variants, serotypes
Ogawa or Inaba. This phenotypic difference is due to the presence or absence of a methyl
group on the terminal perosamine sugar of the surface LPS [5]. Isolates serotype as Ogawa if
the O1 serogroup LPS is methylated and as Inaba if the LPS is not methylated [6]. Methylation
is catalyzed by a methyltransferase encoded by the wbeT (formerly called rbfT [7]) gene and
inactivatingmutations in this gene result in the Inaba serotype. Both serotypes cause cholera
outbreaks with no obvious differences in pathology [8]. Switching betweenOgawa and Inaba
serotypes has been noted previously in endemic regions [9–12] but the epidemiological signifi-
cance of the two serotypic variants has hitherto remained largely uninvestigated and poorly
understood, although it has been suggested that the serotype transition might be driven by
acquisition of serotype-specific immunity within the host population [9].
In 2006 a large field trial in Kolkata, India was conducted to test the efficacy of an oral killed
whole cell vaccine [13–15]. Cases of cholera were identified and closely monitored for 3½ years
prior to and 1½ year following immunization. This included cataloguing every case of severe
cholera (culture confirmed cases from patients seeking treatment and showing acute dehydra-
tion), defining the GPS coordinates of the dwelling of each patient, culturing and serotyping
the responsible O1 V. cholerae and obtaining the complete genome sequence of almost 90%
of all isolates collected.During this period there was a shift in the serotype of isolates causing
disease fromOgawa to Inaba followed by a second shift back to Ogawa. The current paper
describes the relationships between the organisms isolated from patients living in the Kolkata
study area between 2003 and 2008. We used the genomic data from the isolated bacteria to
determine their detailed relationships and genetic makeup. This allowed us to follow the emer-
gence and fate of individual lineages giving new insights into the forces that may be driving the
observed serotype transitions.
Methods
Selection of the catchment area, sampling, and serotype determination
The data presented in this paper are from positive diagnosis tests from cholera patients in a
surveillance study 3 years prior to and two years after an oral killedwhole cell cholera vaccine
trial in the same area. The design of the vaccine trial including the choice of field site has been
describedpreviously and the trial is registered with ClinicalTrials.gov, number NCT00289224
[15]. The sampling, culturing and serotyping of the isolated organisms were done according to
standard procedures [16].
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Whole genome sequencing and analysis of the wbeT gene
Genomic sequencing was done at the Sanger Institute using DNA isolated at NICED. Genomic
libraries were prepared for each sample, followed by multiplex sequencing on an Illumina
HiSeq. The 101–base paired–end reads obtained were mapped against the reference V. cholerae
N16961 El Tor (AE003852 and AE003853), SNPs in the core genome were identified and these
SNPs were used to generate a phylogeny based on the core genome as describedpreviously
[17].
To investigate the population structure of V. cholerae, we interpreted these chromosomal
SNPs usingMaximum likelihood (ML) phylogenetic analysis.
Once the genomic sequencing was done it became apparent that there were a small number
of discrepancies between the serological data and the genomic data when ascribing Inaba or
Ogawa serotypes (19 out of 411). For consistency we assigned serotype for all isolates included
in this study based on the presence of an intact wbeT gene, by manual curation using the
sequence of O1 V. cholerae El Tor strain VX44945 (JF284685) as reference. Strains with an
intact wbeT and surrounding region were deemed to be Ogawa. Strains carryingmutations
caused by insertionwere deemed to be Inaba. Furthermore, strains with mutations in the wbeT
gene that have been associated with the Inaba phenotype in the literature and shown to have
the Inaba phenotype in our laboratory were also deemed to be Inaba. The term geno–serotype
is used to describe the assignment of serotype based on the sequence of the wbeT gene. Strains
with discrepancies in serotype assignment by the different methods were subsequently retested
and it was found that in most cases the geno-serotype could be confirmed serologically.
Ethical statement
The current paper uses data obtained from isolates of Vibrio cholerae cultured from patients
seekingmedical treatment due to diarrhea as a part of routine diagnostic procedures. The
patients were resident within the catchment area for a clinical trial of an oral killedwhole cell
cholera vaccine [15] but not necessarily participants within the trial. Specific isolates can only
be identified by collection date and GPS coordinates of patients’ residence and cannot be linked
to individual patients. DNA was transferred from NICED to the Sanger Institute without any
personal data from the patients from which the isolates were obtained.
Results
Regular seasonal cholera outbreaks in Kolkata municipal wards 29, 30
and 33 in the period 2003–2008
Cholera outbreaks occurred seasonally in each of the years defining the study period, usually in
two waves betweenMarch and September (Fig 1). A total of 462 V. cholerae isolates, all of them
being typed as O1 El Tor, were collected from patients presenting with acute diarrhoea for 3½
years prior to and 1½ year following the first vaccination in the clinical trial in June 2006 (span-
ning the period from January 2003 to December 2007) in Kolkata municipal wards 29, 30, and
33 (Fig 2). Throughout the study the cholera cases from whichV. cholerae were isolated are
referred to as “severe” since the disease symptoms caused the patients to seek treatment at a
health care center.
The cholera cases were widely distributed over the wards, with the greatest concentration
being in ward 29 (Fig 2). Overall in 2005 relatively few cholera cases were reported, amounting
to only 13% of the cases compared to the preceding and following years. When the period of
observation is extended until 2011 using published data from You et al [18] for the same area
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(Fig 1), it can be seen that also in 2011 the occurrence of cases is unusually low and that this
again follows a large outbreak with a lot of cases in a short period in 2010.
Both serotype Inaba and Ogawa cholera outbreaks occurred during the
study period
Looking at the temporal distribution of the isolates causing disease it is clear that both Inaba
and Ogawa isolates were responsible for causing intermittent outbreaks in this area across the
whole study period.However, it is also apparent that the peaks of infectionwere dominated by
either one or the other serotype (Fig 1). When Ogawa infections were dominant in general no
Inaba strains were isolated except in the transition period in 2004 when Inaba strains began to
emerge as clinical isolates and in 2007 when the number of Inaba isolates was in sharp decline.
Thereafter there were no recorded Inaba cases in cholera patients for at least the following five
years [18]. In contrast, during the two-year period 2005–06 when Inaba predominated Ogawa
strains were also isolated (Fig 1). There was no perceptible geographical demarcation between
the Ogawa and Inaba serotype strains (Fig 2)
Phylogenetic relationships in the temporal distribution of Ogawa/Inaba
isolates
Of the 462 V. cholerae isolates collected, 411 were successfully genome sequenced. Sequencing
probably failed in the remainder of the samples due to poor DNA quality resulting from degra-
dation in transit from India to the UK.
The genomic analysis showed that all sequenced isolates fall within the previously described
“wave three” of the global pandemic 7 lineage of V. cholerae biotype El Tor [17]. The isolates
could be divided into four clades on the basis of the clustering pattern in the phylogenetic tree
as indicated in Fig 3. In general, definable outbreaks could be explained by the expansion of
one predominant clade, even though there were usually bacteria from at least two clades
Fig 1. Cholera cases recorded in municipal wards 29, 30 and 33 in Kolkata. All cases of cholera
showing serotype of isolated strains, Ogawa (blue solid line) and Inaba (red dotted lined), over the period
from March 2003 until the end of 2007, shown per month. The blue dashed line shows the cases recorded
over an extended period within the same area of Kolkata until the end of 2011 [18]. There are generally
seasonal outbreaks with one in the spring and one in the autumn.
doi:10.1371/journal.pntd.0005044.g001
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causing disease during any outbreak period (Fig 4). Clade III isolates were predominantly
Ogawa with a few sporadic Inaba strains isolated from 2004 to 2006. Isolates from Clade IV
were predominantly Inaba first appearing in 2004 although a number of Ogawa strains from
this clade were also isolated in 2006 and 2007.
Mutations in wbeT causing the Inaba phenotype are not uniform
Sequence analysis of the wbeT gene, whose inactivation is responsible for the Inaba serotype
classification, showed that across the Inaba isolates there were multiple different mutations pres-
ent within this gene that could explain the inactivation of WbeTmethylation activity (Fig 5).
Within Inaba isolates of Clade III (associated with a minority of the isolated cases of Inaba chol-
era) two types of mutation were seen: either a nonsynonymous single base substitution (M1I)
that disrupts the initiation of translation, or insertion elements (similar to SXT IS4 family
Fig 2. The distribution of cholera cases. The three wards of Kolkata (29, 30 and 33) in which the study was conducted showing all the documented
cases of cholera according to the GPS coordinates of the patients. Green X represents project health clinics, blue and red dots represent Ogawa and
Inaba serotyped cases respectively.
doi:10.1371/journal.pntd.0005044.g002
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Fig 3. Phylogenetic relationships showing four distinct clades. A phylogenetic tree summarizing the
data accumulated in the described study indicating the clade, serotype and year of isolation. It can be seen
that the strains cluster by clade regardless of which of the criteria is used. There is however a striking
correlation between the year of isolation and serotype. Key: Blue and red lines in the tree indicate serotype;
Ogawa and Inaba respectively. The colored bar indicates the year of isolation; light blue = 2003,
yellow = 2004, orange = 2005, light green = 2006, and dark green = 2007. The stars on the tree indicate
strains in which inserts in the wbeT gene or mutations other than S158P - have been identified. The filled star
indicates Inaba strains in Clade III resulting from a clonal expansion of an Inaba strain with an insertion in the
wbeT gene. The additional Inaba strains in Clade III result from an M1I substitution (indicated by two stars).
doi:10.1371/journal.pntd.0005044.g003
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transposase gene [gb|KC709654.1|] or Vibrio cholerae 569b mega-integron [gb|AF179596.1|])
that disrupted the gene by introducing a stop codon. In Clade IV, (associatedwith the large
Inaba outbreaks of 2006) all of the 128 Inaba isolates had an identical SNP(ACT!CCT) result-
ing in an amino acid substitution, S158P in the translated protein leading to inactivation with
Fig 4. Timeline of all strains according to clade. Diagram showing the total number of cholera cases that occurred in the surveyed area
during the period from March 2003 to December 2007 divided to show the time line for each of the four identified clades. The blue (solid) lines
represent Ogawa strains and the red (dotted) lines represent Inaba strains.
doi:10.1371/journal.pntd.0005044.g004
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respect to methylation of LPS; five of these strains also carried insertion elements similar to Vib-
rio cholerae 569b mega-integron (gb|AF179596.1|) and/or IS1358 (gb|U93589.1|) in the wbeT
gene.
Clade IV isolates persisting after 2006 had the Ogawa serotype
The Inaba outbreaks in 2006 were caused almost exclusively by Clade IV. Strikingly however,
although the majority of this clade carry an inactivatingmutation in wbeT a cluster of Clade IV
Ogawa isolates emerged that had apparently reverted to the wild typewbeT gene by the loss of
the non-synonymous SNP (ACT!CCT resulting in the S158P mutation). The first Ogawa
revertant appeared in June of 2006. More than a year later, in the autumn of 2007, the strain
had expanded and several more Ogawa cases from the same lineage were isolated. At this time
no Clade IV Inaba strains were isolated from cholera patients (Fig 4). Thus in 2007 the Ogawa
serotype re-emerged as the sole cause of cholera due to the expansion of two distinct lineages
(Clades III and IV) one of which arose as the result of a reversion mutation of an Inaba strain
from Clade IV.
Discussion
The presented data represents a detailed whole genome-based dissection of V. cholerae O1 iso-
lates causing repeat outbreaks of cholera in Kolkata, India over a five-year period. The results
show clearly the emergence and subsequent disappearance of Inaba serotype isolates in an
endemic area where the Ogawa serotype predominates as the cause of endemic cholera.
The generally accepted view of cholera outbreaks is that in most circumstances there is an
index case that sheds large numbers of virulent bacteria into the environment contaminating
food and water-sources and also spreading infection by family contacts [19]. In non-endemic
areas this is likely to be the case since cholera is introduced into an area where it was previously
absent. However, the presented data show that in a highly endemic area such as the one studied
in Kolkata there are several closely related clades present of 7th pandemic O1 V. cholerae, all of
which cause cholera even though expansions of individual clades account for most of the cases
in any particular outbreak. The state of flux of the different clades in the area is evidencedby
the disappearance of Clades I and II which ceased to be isolated after 2004, and the persistence
of Clade III as a cause of cholera throughout the period.
Fig 5. Schematic diagram of the wbeT gene showing mutations giving rise to the Inaba serotype in the current study. The insertions and
the M1I mutations were confined to Clade III and the S158P mutation was confined to clade IV. In all there were 219 isolates in Clade III. The
insertion at amino acid position 49 occurred in seven isolates and the insertions at 97 and 147 were present in a single isolate. Two strains were
isolated with the M1I mutation. The remaining 209 isolates were Ogawa. In Clade IV there were 139 isolates. Of these 128 were Inaba due to the
S158P mutation and 11 were Ogawa due to a reversion event. 5 out of the 128 Inaba isolates in Clade IV carried multiple insertions in addition to
the S158P mutation (not shown).
doi:10.1371/journal.pntd.0005044.g005
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The data shows that there was a clear point where there was a change in the serotype of the
organisms causing clinical cholera from exclusively Ogawa towards predominantly Inaba cul-
minating in major Inaba outbreaks in 2006. These outbreaks can be attributed to a clonal
expansion of Clade IV. However, the emergence and continued presence of two lineages carry-
ing different mutations leading to the same phenotype (non-methylated LPS serotyping as
Inaba) emerging at almost the same time suggests that the phenotype itself was of importance
for the persistence of these strains during this period and that the transition fromOgawa to
Inaba cannot be explained by an Inaba index case. Indeed, it is notable that Clade III Inaba
strains were the first to be isolated but did not expand to a significant extent compared to
Clade IV Inaba strains that were first isolated three months after the first Inaba isolates
appeared in 2004 and yet did not cause significant outbreaks until 2006. Whether this was due
to conditions not being conducive to a cholera outbreak until 2006 or whether it reflects a dif-
ference in the ability of the different Inaba strains to expand and persist is open to question.
The disappearance of Inaba isolates from patients in contrast was abrupt and also character-
ized by the emergence of two lineages. Clade III Ogawa isolates again predominated, but there
was also an expansion of a Clade IV lineage in which there was a reversion of the wbeT gene
back to the active form. There were no Inaba strains from Clade III isolated after the first half
of 2007 and, although there is no genomic data after 2007, no Inaba strains were isolated in the
area during the next five years of follow-up.
It has previously been shown that the core genome of Vibrio cholerae accumulates approxi-
mately 3.3 SNPs per genome per year [17]. The wbeT gene in Ogawa strains is highly conserved
with no synonymous SNPs observedeither in publishedwbeT from El Tor O1 V. cholerae
sequences fromGenBank, in our own large geographically and temporally diverse strain collec-
tion (unpublished results) or in the current study (273 isolates). However, in the current study
despite the low overall diversity between the isolates, in isolates of the Inaba serotype two differ-
ent SNPs and at least 7 independent insertion events in thewbeT gene were observed in less than
three years. It is unlikely that the near-simultaneous emergence of multiple lineages with different
mutations in thewbeT gene leading to the same phenotypic change was a random event. It seems
more likely that specific non-random triggers precipitated both the emergence and subsequent
disappearance of the Inaba isolates. At present the nature of such trigger(s) is unclear. It has been
suggested that expansion of vibriophage populations is a factor that limits cholera outbreaks [20];
hence the presence of a serotype-specificphage could possibly explain the decline in Ogawa iso-
lates and the emergence of insensitive Inaba strains and vice versa. The sudden decline in the
number of Ogawa cases and the first relatively slow emergence of Inaba could reflect initial selec-
tion against Ogawa isolates combined with a low number of Inaba strains in the environment.
These studies show that the wbeT gene is highly conserved yet under certain circumstances
inactivatingmutations are readily isolated by what appears to be a driven process. The overall
strong conservation of the wbeT gene suggests that it has an important role whereas the ease
with which mutants can be isolated at times suggests that under certain conditions the change
to Inaba may contribute to the ability of V. cholerae O1 to persist in an endemic environment.
Although the presented study provides a detailed picture of strains causing severe cholera
over time in an area where the disease is endemic, it is also limited. Only samples from patients
with clinical disease were analyzed representing only a fraction of all cholera strains in the
study population since the majority of cholera infections result in milder symptoms or are
asymptomatic [21]. We also have no data concerning environmental bacterial populations.
Furthermore, the data was collected in association with a clinical trial of a cholera vaccine and
whereas the first serotype transition occurred before the first vaccinations in 2006 and can
have had no influence on the initial Ogawa to Inaba serotype shift, some effect of the vaccina-
tion on the subsequent transition back to Ogawa cannot be ruled out.
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Nonetheless, the detailed data are able to differentiate lineages in a way that provides a valu-
able novel insight into their persistence and spread in an endemic area and suggest that the
dynamics are more complex than previously thought. Furthermore, although no comparable
studies have been done, the occurrence of the same sorts of mutation in the wbeT gene from
isolates from different outbreaks in different parts of the world suggest that our observations
do not represent a unique event [22–26].
Clearly further work needs to be done to address the factors contributing to the persistence
and spread of cholera in endemic areas. However, our data suggests that shifts in serotype of
O1 V. cholerae causing cholera are being driven by as yet undeterminednon-randommecha-
nisms and that mutations in the wbeT gene associated with serotype switching could be of
importance for persistence of cholera in endemic areas. It remains to be tested whether it is the
serotype shift alone that is important in this regard or whether the wbeT gene might have addi-
tional function; it is notable that Inaba strains isolated during outbreaks both in the present
study and from elsewhere characteristically display single-point mutations in wbeT allowing
for a full-length protein product in contrast to the Inaba isolates from the sporadic (non-epi-
demic) cholera cases in the present study that without exceptions had wbeTmutations incom-
patible with full-length protein translation.
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